JOHN ABALLI is listed as an executive officer on 5 SEC Form D filings by 1 issuer between Sep 2018 and May 2020: DECIPHER BIOSCIENCES, INC. (San Diego, CA — other health care — 2018–2020; $25.4M reported sold to 41 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside BRENT VETTER (5 shared filings), ELAI DAVICIONI (5 shared filings), HENRY SKINNER (5 shared filings), TODD HOLMES (5 shared filings), Tina S. Nova (5 shared filings) and 9 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around JOHN. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 5 public filings for JOHN ABALLI and found 3 differences, 1 worth asking the sponsor about: Form D filed 67 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.